The three common apolipoprotein E (ApoE) alleles differentially contribute to the risk of Alzheimer's disease (AD). While the APOE genotype alters susceptibility to disease expression, individuals with APOE ⑀4 alleles have the highest risk of developing AD; the APOE ⑀4 allele is neither essential nor sufficient on its own to cause AD. Since the discovery, in 1992, of the involvement of APOE in AD, many scientists have explored the role of the ApoE isoforms in the central nervous system in an effort to elucidate their roles in the pathophysiological mechanism of this disease. While many hypotheses have been proposed, none has been proven. ApoE was discovered through investigations into cholesterol metabolism. In serum and in cerebrospinal fluid ApoE binds lipoprotein particles, which contain cholesterol esters, and is critical in the shuttling of cholesterol from cell to cell. Trafficking of ApoE is mediated by specific interactions with cell-surface receptors. As described later, several families of ApoE receptors with diverse functions have been discovered. The roles of these receptors are proving increasingly complex since additional interactions with other ligands and with other intracellular proteins are rapidly being identified. It was once thought that these receptors only shuttle ApoE-containing phospholipid particles from the extracellular environment into the cell, but they also transduce a number of additional intracellular signals and interactions. Molecular signalling cascades initiated by the various ApoE receptors modulate a number of critical cellular processes. To date, two functional classes of ApoE receptors have been identified. The first is the low-density lipoprotein receptor family and the second the scavenger receptor families.
The low-density lipoprotein (LDL) receptor family
The most extensively investigated ApoE receptors are a family of seven receptors in the LDL receptor gene family. These receptors share common molecular features critical for their roles in binding and internalizing ApoElipoprotein particles and regulating intracellular cholesterol metabolism. Receptors in this class are the LDL receptor, the very-low-density lipoprotein (VLDL) receptor, neuro-ApoE receptor (LR8B), vitellogenin (two related receptors), LDL receptor-related protein (LRP) and megalin (gp330) [1] .
Functional domains of the LDL receptor family
ApoE receptors in this family share functional motifs. Two representative LDL receptors, LRP and LR8B are shown in Figure 1 . All receptors in this family are single transmembrane-spanning receptors with their C-terminus in the cytoplasmic compartment. The extracellular N-terminus of these receptors includes ligand binding domains. Each of these ligand binding domains is approximately 40 amino acids long. The LDL receptor contains six of these domains, and the largest ApoE receptor, megalin, contains 36. These individual ligand binding domains share amino acid sequences, with approximately 50% homology both within and among these receptors. All receptors in this class recognize and bind ApoE, but details of the kinetics and the specificity for interactions with the various isoforms of ApoE have only been extensively studied for the LDL receptor [1] . Several of these receptors interact with other ligands in addition to ApoE (see Figure 2) . The LDL receptor appears to interact only with ApoE and ApoB. In contrast, the LRP receptor also binds ␣ 2 -macroglobulin, the ␤-amyloid precursor protein (APP), thrombospondin, plasminogen activators and Pseudomonas exotoxin A [2] . The receptor-associated protein (RAP) is a 39 kDa protein which associates with the nascent receptor as it is translated in the endoplasmic reticulum. It appears to play an important role in ensuring that the correct tertiary structure of the receptor is reached and in preventing indiscriminate association of the receptor with other molecules. It also competitively inhibits ApoE from interacting with this class of receptors, and has therefore been used as a pharmacological tool to determine whether an effect of ApoE is mediated by interaction with this class of receptors.
In addition to the ApoE ligand binding domains, the extracellular domain of these receptors contains an epidermal growth factor (EGF)-precursor domain. Deletion of this EGF-precursor domain prevents these receptors from binding to LDL, but has no effect on their binding to ApoE. The EGF-precursor domain appears necessary for mediating the pH-dependent dissociation of ligand from receptor [1] .
The third functional domain of the LDL receptor family is within the cytoplasmic domain of the receptor and is necessary for interactions between the receptor protein and other proteins in the cytoplasm. Neuronal ApoE receptors contain the consensus sequence NPxY (found twice in the cytoplasmic domain of LRP and megalin). This sequence was initially identified as the domain necessary for the localization of the receptors in coated pits; this occurs through its interaction with the adaptor protein AP-2 which in turn binds clathrin. The role of this protein-protein interaction in receptor-mediated endocytosis is described in the next section. Additional interactions of the cytoplasmic domain of these receptors, recently identified by Joachim Herz and colleagues, present additional signalling transduction pathways for these receptors. Using yeast two-hybrid and protein co-immunoprecipitation techniques he demonstrated that the cytoplasmic domains of these proteins interact with the neuronal adaptor proteins FE65 and mammalian Disabled (DAB), as shown in Figure 3 [3] . These proteins in turn interact with other cytoplasmic proteins, discussed later. Intriguingly, APP also contains an NPxY consensus sequence and interacts with FE65 [3] and DAB [4] .
Cellular trafficking of the LDL receptor family
With a turnover time of approximately 10 minutes, the LDL family of receptors bind ApoE-containing lipoprotein particles, and internalize them within the cell (Figure 4) [2] . These receptors locate in the coated pits of the plasma membrane through interactions with the cytoplasmic protein clathrin, which are mediated by the adaptor protein AP-2. After invagination of the coated pit, the newly formed coated vesicle fuses to form an acid endosome. The decrease in pH dissociates the receptor from the ligand, and the receptor is recycled to the plasma membrane. Acid hydrolases free the cholesterol from the ApoE-containing lipoprotein particles and the cholesterol then enters the cytoplasmic compartment.
Receptor transduction through DAB
The binding of the cytoplasmic tail of the LDL receptor family to DAB presents additional opportunities for signal transduction [3] . DAB is primarily a neuronal protein which contains a single protein-interaction domain. DAB is tyrosine phosphorylated by the non-receptor tyrosine kinases SRC and ABL ( Figure 5 ). Knockout of the DAB gene produces a lethal neurological phenotype characterized by abnormal cortical cell-layering.
Receptor transduction through FE65
FE65 is another protein which binds to the cytoplasmic tail of these receptors [3] . Unlike DAB, FE65 contains three protein binding domains, presenting the opportunity for molecular scaffolding. FE65 contains two distinct binding domains that bind both the LDL family of receptors and also APP, suggesting a mechanism by which the metabolism of these receptors may be linked. FE65 also contains a WW domain capable of binding mammalian enabled (MENA). MENA in turn is implicated in the control of microfilament dynamics by enhancing the formation of f-actin filaments through interactions with its binding partner profilin ( Figure 6 ) [5] .
Calcium transients induced by ApoE
ApoE transiently increases intraneuronal calcium. Müller and colleagues demonstrated that ApoE increases free calcium concentrations in hippocampal neurons, with ApoE4ϾApoE3ϾApoE2 [6] . This calcium transient is inhibited by agatoxin-IVa, suggesting a P/Q type calcium channel. The ApoE receptor mediating this effect was not determined. In a more recent study Tolar demonstrated that ApoE peptides, or truncated ApoE, also increase calcium concentrations in rat hippocampal neurons [7] . This effect of ApoE was inhibited by RAP, suggesting that interaction occurs through an LDL receptor family member. 
ApoE scavenger receptors
Scavenger receptors of ApoE-containing LDL were initially identified on macrophages and have been extensively studied for their role in the binding and subsequent metabolism of chemically modified LDL particles. Scavenger receptors bind oxidized LDL, acetylated LDL and maleylated LDL, but do not bind native, unmodified LDL. Similar to the LRP receptor described previously, scavenger receptors are multi-ligand receptors. After binding scavenger receptors, these modified LDL particles are subsequently internalized and degraded in lysosomes. These receptors are thought to be critical in the conversion of the macrophage to the cholesterol-laden foam cell and are critical in the pathophysiology of atherosclerosis.
Class A scavenger receptors
Class A scavenger receptors are homotrimeric proteins ( Figure 7) , with six functional domains: an N-terminus cytoplasmic domain, a single transmembrane-spanning domain, a spacer domain, an ␣-helical coiled coil domain, a collagen-like repeat and a cysteine-rich domain (found on one type of scavenger receptor) [8] .
Class B scavenger receptor SR-B1
In contrast to the Class A scavenger receptors, which contain a charged collagenous receptor domain, Class B receptors are a more heterogeneous group of receptors containing an immunodominant ligand binding domain. The dominant ligand for this class of receptors is the high-density lipoprotein particle (HDL) which does not contain ApoE. However, one of these receptors, SR-B1, also binds both LDL and modified LDL, which contain ApoE. SR-B1 appears to have both its N-and C-termini in the cytoplasm (Figure 8 ) [9] . The SR-B1 receptor appears concentrated in the caveoli of the plasma membrane and co-purifies with caveolin. Although SR-B1 binds HDL and LDL, and internalizes cholesterol, the apolipoproteins themselves are not internalized. This observation generates the hypothesis that this receptor is involved in the non-endocytotic internalization of cholesterol esters, and also in reverse cholesterol transport.
Lectin-like oxidized-LDL receptor (LOX-1)
LOX-1 is another receptor for oxidized LDL. Unlike the Class A receptors described above, which are found primarily on macrophages, LOX-1 is highly expressed in endothelial cells and in the brain [10] . The LOX-1 gene is closely related to C-type lectin receptor genes expressed in natural killer cells, and the receptor proteins share common structural and functional motifs.
Conclusion
Although ApoE has been extensively studied for its role in cholesterol metabolism through its ability to bind phospholipid particles, and is a ligand for cell-surface receptors which undergo endocytosis, ApoE metabolism is far more complex. Of relevance to roles in the central nervous system, ApoE binds other molecules including growth factors, basement membrane proteins, and the ␤-amyloid peptide. It is oxidatively modified in the central nervous system, 
